1. Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition
   Sally A. Fahim et al, 2024, Scientific Reports CrossRef
2. The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review
   Kai Liu et al, 2020, Cancer Cell International CrossRef
3. Integrating computational methods guided the discovery of phytochemicals as potential Pin1 inhibitors for cancer: pharmacophore modeling, molecular docking, MM-GBSA calculations and molecular dynamics studies
   Abdulrahim A. Alzain et al, 2024, Frontiers in Chemistry CrossRef
4. Prolyl isomerase Pin1: a promoter of cancer and a target for therapy
   Yang Chen et al, 2018, Cell Death & Disease CrossRef
5. Proteomics Approaches for the Discovery of Potential Enzymatic Biomarkers for Early Diagnosis of Breast Cancer
   Yingxi Li et al, 2023, The 2nd International Electronic Conference on Biomedicines CrossRef